Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2024

Substrates of ADAM17 sheddase in airway and blood samples of patients with asthma and healthy individuals

View Full Paper
Ask AI
Bookmark
Share

Authors

CLCaroline LarssonLund UniversityNBNicole van der BurgLund UniversityJAJaro AnkerstLund University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Larsson et al. (2024) studied this question.

synapsesocial.com/papers/68e73ed6b6db6435876b8a08https://doi.org/10.1183/23120541.lsc-2024.36
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting ADAM17 to dampen dendritic cell-mediated type 2 immune responses and airway inflammation associated with allergic asthma2025 · 1 citations
  2. 2ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets2014 · 145 citations
  3. 3Endothelial ADAM17 facilitates neutrophil migration and pulmonary microvascular permeability in acute lung inflammation2026
  4. 4ASSOCIATION OF THE ADAM33 GENE WITH ASTHMA AND BRONCHIAL HYPERRESPONSIVENESS2003 · 88 citations
  5. 5ADAM33: a novel therapeutic target for asthma2003 · 12 citations